NCT06888479
Optimal Timing of Hepatitis B Vaccination After Transplants
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Withdrawn before enrolling Sponsor's reason: Insufficient execution and compliance Show 5 more changesShow less
- Enrollment target: estimated 1500 to confirmed 0
- Start date changed from estimate of Jun 1, 2025 to Jan 1, 2026
- Eligibility criteria expanded, about 9 words
- Primary completion date changed from estimate of Jun 1, 2028 to Jan 1, 2026
- Site details revised
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
Endpoints
Primary
Secondary (1)
Arms and interventions
Patients with composite immune risk score (CIRS) ≤ 2.5 and being assigned to receive 3 doses of hepatitis B vaccine at 3, 4, and 9 months after transplantation.
Patients with CIRS \> 2.5 and being assigned to receive 3 doses of hepatitis B vaccine at 3, 4, and 9 months after transplantation.
Patients with CIRS ≤ 2.5 and being assigned to receive 3 doses of hepatitis B vaccine at 6, 7, and 12 months after transplantation.
Patients with CIRS \> 2.5 and being assigned to receive 3 doses of hepatitis B vaccine at 6, 7, and 12 months after transplantation.
Biologicals: hepatitis B vaccine
Sites
1 site in 1 country
- Institute of Hematology & Blood Diseases HospitalTianjin, Tianjin Municipality, China